Summary
Telomeres are specialized structures consisting of repeat arrays of TTAGGGn located at the ends of chromosomes. They are essential for chromosome stability and, in the majority of normal somatic cells, telomeres shorten with each cell division. Most immortalized cell lines and tumours reactivate telomerase to stabilize the shortening chromosomes. Telomerase activation is regarded as a central step in carcinogenesis and, here, we demonstrate telomerase activation in premalignant skin lesions and also in all forms of skin cancer. Telomerase activation in normal skin was a rare event, and among 16 samples of normal skin (one with a history of chronic sun exposure) 12.5% (2 out of 16) exhibited telomerase activity. One out of 16 (6.25%) benign proliferative lesions, including viral and seborrhoeic wart samples, had telomerase activity. In premalignant actinic keratoses and Bowen’s disease, 42% (11 out of 26) of samples exhibited telomerase activity. In the basal cell carcinoma and cutaneous malignant melanoma (CMM) lesions, telomerase was activated in 77% (10 out of 13) and 69% (22 out of 32) respectively. However, only 25% (3 out of 12) of squamous cell carcinomas (SCC) had telomerase activity. With the exception of one SCC sample, telomerase activity in a positive control cell line derived from a fibrosarcoma (HT1080) was not inhibited when mixed with the telomerase-negative SCC or CMM extracts, indicating that, overall, Taq polymerase and telomerase inhibitors were not responsible for the negative results. Mean telomere hybridizing restriction fragment (TRF) analysis was performed in a number of telomerase-positive and -negative samples and, although a broad range of TRF sizes ranging from 3.6 to 17 kb was observed, a relationship between telomerase status and TRF size was not found.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allsop, R. C., Chang, E., Kashafi-Aazam, Rogaeu, E. I., Piatyszek, M. A., Shay, J. W. & Harley, C. B. (1995). Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194–200.
Anand, R. (1986). Pulsed field gel electrophoresis: a technique for fractionating large DNA molecules. Trends Genet 2: 278–283.
Bacchetti, S. & Counter, C. M. (1995). Telomeres and telomerase in human cancer. Int J Oncol 7: 423–432.
Blasco, M. A., Lee, H-W, Prakash-Hande, M., Samper, E., Landsdorp, P. M., DePinho, R. A. & Greider, C. W. (1997). Telomere shortening and tumour formation by mouse cells lacking telomerase RNA. Cell 91: 25–34.
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J. & Ponten, J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88: 10124–10128.
Broccoli, D., Young, J. & de Lange, T. (1995). Telomerase activity in normal and malignant hemopoietic cells. Proc Natl Acad Sci USA 92: 9082–9086.
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R. R. (1995). Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240–4248.
Bryan, T. M., Marusic, L., Bacchetti, S., Namba, M. & Reddel, R. R. (1997a). The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 6: 921–926.
Bryan, T. M., Englezou, A., Dalla-Pozzah, L., Dunham, M. A. & Reddel, R. R. (1997b). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med 3: 1271–1274.
Flores, J. F., Walker, G. J., Glendening, J. M., Halsuka, F. G., Castresana, J. S., Rubio, M. P., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., Barnhill, R. L., Hayward, N. K., Housmann, D. E. & Fountain, J. W. (1996). Loss of the p16INK4a and p15INK4bgenes, as well as neighboring 9p21 markers in sporadic melanoma. Cancer Res 56: 5023–5032.
Greider, C. W. (1994). Mammalian telomere dynamics: healing fragmentation, shortening and stabilization. Curr Opin Genet Dev 4: 203–211.
Harle-Bachor, C. & Boukamp, P. (1996). Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476–6481.
Harley, C. B. (1991). Telomere loss: mitotic clock or genetic time bomb. Mutat Res 256: 271–282.
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K. & Allshire, R. C. (1990). Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866–868.
Holt, S. E., Wright, W. E. & Shay, J. W. (1996). Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932–2939.
IARC (1992). Monograph on the evaluation of carcinogenic risk to humans. Solar and Ultraviolet Radiation, vol. 55, IARC: Lyon
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L. & Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 226: 2011–2015.
Kyo, S., Takakura, M., Kohama, T. & Inoue, M. (1997). Telomerase activity in human endometrium. Cancer Res 57: 610–614.
Lundblad, V. & Blackburn, E. H. (1993). An alternative pathway for yeast telomere maintenance rescues estl–senescence. Cell 73: 347–360.
McClintock, B. (1941). The stability of broken ends of chromosomes in Zea mays. Genetics 41: 234–282.
McEachern, M. J. & Blackburn, E. H. (1996). Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev 10: 1822–1834.
Morin, G. B. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521–529.
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L. & Wu, J. R. (1988). A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622–6626.
Muller, H. J. (1938). The remaking of chromosomes. The collecting net. Woods Hole 13: 181–198.
Murnane, J. P., Sabatier, L., Marder, B. A. & Morgan, W. F. (1994). Telomere dynamics in an immortal human cell line. EMBO J 13: 4953–4962.
Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Himaya, K., Himaya, E., Wright, W. E. & Shay, J. W. (1995). Detection of telomerase activity in human cells and tumours by a telomeric repeat amplifictaion protocol (TRAP). Methods Cell Sci 17: 1–15.
Rogan, E. M., Bryan, T. M., Hukku, B., Maclean, K., Chang, AC-M, Moy, E. L., Englezou, A., Warneford, S. G., Dalla-Pozza, L. & Reddel, R. R. (1995). Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalisation of Li–Fraumeni syndrome fibroblasts. Mol Cell Biol 15: 4745–4753.
Rhyu, M. S. (1995). Telomeres, telomerase, and immortality. J Natl Cancer Inst 87: 884–894.
Silver, A., George, A., Masson, W., Breckon, G., Adam, J. & Cox, R. (1991). DNA methylation changes in the IL-1 (2F) chromosomal region of radiation induced acute myeloid leukaemias carrying chromosome 2 rearrangements. Genes Chromosomes Cancer 3: 376–381.
Taylor, R. S., Ramirez, R. D., Ogoshi, M., Chaffins, M., Piatyszek, M. A. & Shay, J. W. (1996). Detection of telomerase activity in malignant and non-malignant skin conditions. J Invest Dermatol 106: 759–765.
Ueda, M., Ouhtit, A., Bito, T., Nakazawa, K., Lubbe, J., Ichihashi, M., Yamasaki, H. & Nakazawa, H. (1997). Evidence for UV-associated activation of telomerase in human skin. Cancer Res 57: 370–374.
Wainwright, L. J., Middleton, P. G. & Rees, J. L. (1995). Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromes Cancer 12: 45–49.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Parris, C., Jezzard, S., Silver, A. et al. Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer 79, 47–53 (1999). https://doi.org/10.1038/sj.bjc.6690010
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690010
Keywords
This article is cited by
-
The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulators
Longevity & Healthspan (2014)
-
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma
Modern Pathology (2014)
-
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Virchows Archiv (2014)
-
Association between TERT-CLPTM1L rs401681[C] allele and NMSC cancer risk: a meta-analysis including 45,184 subjects
Archives of Dermatological Research (2013)
-
Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors
BMC Cancer (2010)